Clinical Trials Logo

Metabolic Syndrome X clinical trials

View clinical trials related to Metabolic Syndrome X.

Filter by:

NCT ID: NCT03490097 Completed - Metabolic Syndrome Clinical Trials

Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination

Start date: December 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to determine if statin can affect the clinical outcome of chronic hepatitis C patients receiving Sofosbuvir/Daclatasvir/Ribavirin combination

NCT ID: NCT03488992 Completed - Metabolic Syndrome Clinical Trials

Effect of a MVM Dietary Supplement on Indices of Human Health

Start date: January 10, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the health benefits of a recently developed multimineral/multivitamin/phytochemical (MVM/phytochemical) nutritional supplement. This newly developed supplement - an advancement of a previous formula designed to enhance human health by providing RDA-levels of essential vitamins and minerals - contains eight phytochemicals selected to address fruit and vegetable undernutrition, and chosen on the basis that: 1) published research from cell culture, animal model and, when available, human clinical work, suggests that it may benefit human health, and 2) it is considered safe for human ingestion at proposed levels of consumption.

NCT ID: NCT03478046 Completed - Obesity Clinical Trials

Fetuin-A Phosphorylation Status in Insulin Resistance and Metabolic Syndrome

Start date: October 10, 2007
Phase: N/A
Study type: Interventional

Fetuin-A has been identified as a novel physiological regulator of insulin action in vitro, in intact cells and in vivo in animals. Previous research has shown that circulating levels of fetuin-A were increased in animal models of insulin resistance and diabetes. Additionally, several human investigation studies demonstrate a correlation of fetuin-A levels with body mass index, insulin resistance, and a fatty liver. Recently, the investigators have elucidated the role of fetuin-A phosphorylation in the regulation of insulin action, demonstrating that phosphorylation is critical for the inhibitory activity of fetuin-A. The objectives of this study are twofold: (1) Quantitate phosphorylated fetuin-A levels in individuals with insulin resistance and metabolic syndrome, and (2) Investigate the effects of lifestyle modifications (acute or chronic exercise and dietary modifications) on fetuin-A phosphorylation and insulin sensitivity.

NCT ID: NCT03477773 Completed - Metabolic Syndrome Clinical Trials

Development of an Exergame to Deliver a Sustained Dose of High-Intensity Training

Start date: November 1, 2014
Phase: N/A
Study type: Interventional

Males from areas of social deprivation within the town of Middlesbrough (UK) were targetted and recruited on to a high-intensity, exergaming intervention over a 6-week period. Eligible participants were randomly allocated to an intervention group (weekly exergaming) or control group (normal habitual lifestyle). All participants completed baseline (week 0) and follow-up (week 7) measures of metabolic health. Participants in the intervention group were invited to three sessions a week of high-intensity exergaming performed against their peers on a developed boxing game.

NCT ID: NCT03447028 Completed - Prostate Cancer Clinical Trials

Effect of TyG Index on Outcomes of Radical Prostatectomy

TyG-PCa
Start date: January 1, 2007
Phase: N/A
Study type: Observational [Patient Registry]

We investigate the association between Triglyserid-Glucose(TyG) index and prostate cancer in patients undergoing radical prostatectomy.

NCT ID: NCT03446183 Completed - Metabolic Syndrome Clinical Trials

Short Term Effect of Smoking Cessation on Human Metabolism

Start date: April 18, 2016
Phase: N/A
Study type: Observational

Investigating the short term smoking cessation on metabolism, examining of participant of smoking cessation workshops and former participants' file survey for metabolic aspects

NCT ID: NCT03445741 Completed - Metabolic Syndrome Clinical Trials

Efficacy of Various Aerobic Exercises on Abdominal Obesity in Women With Metabolic Syndrome.

Start date: August 1, 2016
Phase: N/A
Study type: Interventional

Objective: To show metabolic and hormonal responses and effects on abdominal obesity of aerobic exercise in different intensity and duration and detraining period in women with metabolic syndrome.

NCT ID: NCT03444558 Completed - Metabolic Syndrome Clinical Trials

Effects of Natural Supplement Containing Chlorogenic Acid and Luteolin on Cardio-metabolic Risk Factors

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

Clinical trial about beneficial effects of natural ingredient containing chlorogenic acid and luteolin on liver health and conditions related to liver (such as metabolic syndrome) for general body health.

NCT ID: NCT03421444 Completed - Obesity Clinical Trials

Beijing Children and Adolescents Metabolic Syndrome Study (BCAMS Study)

BCAMS
Start date: April 2004
Phase: N/A
Study type: Observational [Patient Registry]

Base on enriched resources from the Metabolic Syndrome cohort in children, a long-term prospective cohort study will be carried out. This cohort is a unique biochemical and genetic database of Chinese population with large number of subjects in the world. By collecting information of disease history and lifestyle, measuring clinical and metabolic parameters, especially biomarkers which can reflect the underlying mechanism of insulin resistance and metabolic syndrome, we intend to sort out some unique biochemical and genetic markers for Chinese population.

NCT ID: NCT03416439 Completed - Clinical trials for Lifestyle Intervention

Effectiveness of a Lifestyle Intervention on Metabolic Syndrome.

Start date: September 2004
Phase: Phase 3
Study type: Interventional

The investigators compared the effectiveness of a lifestyle intervention program carried out by trained professionals versus standard unstructured information on healthy lifestyle given by the family physicians in ameliorating the metabolic pattern of adults with multiple metabolic and inflammatory abnormalities.